Home › Oral Cancer › Ohio › Toledo
Oral Cancer clinical trials in Toledo, OH
4 studies for Oral Cancer are looking for participants at sites in and around Toledo (within about 30 miles). Open a study to see who can join and how to contact the study team.
Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment
RecruitingPhase 3
- ProMedica Flower Hospital, Sylvania · 9 mi away
Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer
RecruitingPhase 2
- ProMedica Flower Hospital, Sylvania · 9 mi away
DESTINY-PANTUMOUR04
RecruitingObservational study
- Research Site, Maumee · 9 mi away
Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive Cisplatin
RecruitingPhase 3
- ProMedica Toledo Hospital/Russell J Ebeid Children's Hospital, Toledo
- ProMedica Flower Hospital, Sylvania · 9 mi away
About Oral Cancer
Oral cancer can form in the mouth or throat but usually begins in the tongue and floor of the mouth. Read about the common oral cancer symptoms.
More about Oral Cancer on MedlinePlus
Oral Cancer trials in other cities
- Atlanta, GA9 studies
- Chicago, IL8 studies
- St. Louis, MO8 studies
- New York City, NY8 studies
- Durham, NC7 studies
- Kansas City, MO7 studies
- Richmond, VA7 studies
- Ann Arbor, MI7 studies
- Milwaukee, WI7 studies
- Pittsburgh, PA7 studies
- Houston, TX7 studies
- Nashville, TN6 studies
Other studies in Toledo
- Non-Small Cell Lung Cancer17 studies
- Ovarian Cancer12 studies
- Lung Cancer11 studies
- Metastatic Cancer10 studies
- Endometrial Cancer9 studies
- Stroke9 studies
- Head and Neck Squamous Cell Carcinoma8 studies
- Melanoma8 studies
- Pancreatic Cancer8 studies
- Colorectal Cancer7 studies
- Esophageal Cancer7 studies
- Cancer (all types)7 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.